Patents by Inventor Tim Ioannides

Tim Ioannides has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230414741
    Abstract: A method for treating or reducing the incidence of recurrence of cancer, benign tumors, or HPV-associated lesions, including skin cancer, and particularly squamous cell carcinoma (SCC and basal-cell carcinoma, by administering to a patient one or more doses of HPV recombinant vaccine as a first active therapeutic agent in combination with a second active therapeutic agent administered concomitantly or as a fixed-dose combination composition.
    Type: Application
    Filed: October 12, 2021
    Publication date: December 28, 2023
    Applicant: HPVVAX. LLC
    Inventors: Tim Ioannides, Evangelos V. Badiavas
  • Patent number: 11813329
    Abstract: A method for treating or reducing the incidence of recurrence of cancer, benign tumors, or HPV-associated lesions, including skin cancer, and particularly squamous cell carcinoma (SCC and basal-cell carcinoma, by administering one or more doses of HPV recombinant vaccine to a patient.
    Type: Grant
    Filed: October 12, 2020
    Date of Patent: November 14, 2023
    Assignee: HPVVAX, LLC
    Inventors: Tim Ioannides, Evangelos V. Badiavas
  • Publication number: 20210030872
    Abstract: A method for treating or reducing the incidence of recurrence of cancer, benign tumors, or HPV-associated lesions, including skin cancer, and particularly squamous cell carcinoma (SCC and basal-cell carcinoma, by administering one or more doses of HPV recombinant vaccine to a patient.
    Type: Application
    Filed: October 12, 2020
    Publication date: February 4, 2021
    Applicant: HPVVAX, LLC
    Inventors: Tim Ioannides, Evangelos V. Badiavas
  • Patent number: 10799574
    Abstract: A method for treating or reducing the incidence of recurrence of cancer, benign tumors or HPV-associated lesions, including skin cancer, and particularly squamous cell carcinoma (SCC and basal-cell carcinoma, by administering one or more doses of HPV recombinant vaccine to a patient.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: October 13, 2020
    Assignee: HPVVAX. LLC
    Inventor: Tim Ioannides
  • Patent number: 10238729
    Abstract: A method for treating or reducing the incidence of recurrence of cancer, benign tumors or HPV-associated lesions, including skin cancer, and particularly squamous cell carcinoma (SCC and basal-cell carcinoma, by administering one or more doses of HPV recombinant vaccine to a patient.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: March 26, 2019
    Assignee: HPVVAX, LLC
    Inventor: Tim Ioannides
  • Publication number: 20170165351
    Abstract: A method for treating or reducing the incidence of recurrence of cancer, benign tumors or HPV-associated lesions, including skin cancer, and particularly squamous cell carcinoma (SCC and basal-cell carcinoma, by administering one or more doses of HPV recombinant vaccine to a patient.
    Type: Application
    Filed: February 24, 2017
    Publication date: June 15, 2017
    Applicant: HPVVAX, LLC
    Inventor: Tim Ioannides
  • Publication number: 20160114023
    Abstract: A method for treating or reducing the incidence of recurrence of cancer, benign tumors or HPV-associated lesions, including skin cancer, and particularly squamous cell carcinoma (SCC and basal-cell carcinoma, by administering one or more doses of HPV recombinant vaccine to a patient.
    Type: Application
    Filed: October 23, 2015
    Publication date: April 28, 2016
    Inventor: Tim Ioannides